| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.31B | +8.2% |
| Cost of Revenue | $1.33B | +5.4% |
| R&D Expense | $47.8M | +3.7% |
| Operating Income | $424.2M | +19.2% |
| Pre-tax Income | $432.8M | +27.9% |
| Income Tax | $101.1M | +43.8% |
| Net Income | $366.6M | +24.4% |
| EPS (Basic) | $6.38 | +23.9% |
| EPS (Diluted) | $6.26 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $506.5M | +65.1% |
| Accounts Receivable | $358.7M | +5.8% |
| Inventory | $376.5M | -1.0% |
| Current Assets | $2.57B | +83.3% |
| Total Assets | $3.85B | +45.9% |
| Current Liabilities | $465.2M | -14.4% |
| Long-term Debt | $1.15B | +364.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $53.5M | +46.2% |
| Financing Cash Flow | $838.8M | +1787.7% |
| +24.0% |
| Stockholders' Equity |
| $2.06B |
| +25.8% |